Work

Results of a European Multicentre Study with Sandostatin® LAR® in Acromegalic Patients

Year: 1999

Type: article

Study design: Clinical Trial

Source: Pituitary

DOI: 10.1023/a:1009980404404

Authors: Ioana Lancranjan, A. Brew Atkinson, Sandostatin® LAR® Group#

Institutions: Novartis (Switzerland), Royal Victoria Hospital

Language: English

Topic: Pituitary Gland Disorders and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W108281130

FWCI: 6.712

Cites: 24

Cited by: 164

Related to: 10